↓ Skip to main content

Advances and perspectives of PARP inhibitors

Overview of attention for article published in Experimental Hematology & Oncology, November 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
82 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Advances and perspectives of PARP inhibitors
Published in
Experimental Hematology & Oncology, November 2019
DOI 10.1186/s40164-019-0154-9
Pubmed ID
Authors

Ming Yi, Bing Dong, Shuang Qin, Qian Chu, Kongming Wu, Suxia Luo

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 82 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 18%
Student > Master 13 16%
Student > Bachelor 13 16%
Student > Doctoral Student 4 5%
Researcher 4 5%
Other 11 13%
Unknown 22 27%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 21 26%
Agricultural and Biological Sciences 9 11%
Medicine and Dentistry 9 11%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Chemistry 5 6%
Other 7 9%
Unknown 25 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2019.
All research outputs
#12,386,279
of 16,241,843 outputs
Outputs from Experimental Hematology & Oncology
#96
of 146 outputs
Outputs of similar age
#261,379
of 385,823 outputs
Outputs of similar age from Experimental Hematology & Oncology
#10
of 20 outputs
Altmetric has tracked 16,241,843 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 146 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 385,823 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.